Each year, an estimated 400 000 children worldwide develop cancer. Most of them live in low- and middle-income countries.

The Global Platform for Access to Childhood Cancer Medicines, established by the World Health Organization and St. Jude Children’s Research Hospital in the United States of America, will dramatically increase access to childhood cancer medicines around the world.

The Platform, the first of its kind, will provide an uninterrupted supply of quality-assured childhood cancer medicines to low- and middle-income countries. It aims to provide safe and effective cancer medicines to approximately 120 000 children between 2022 and 2027, with the expectation to scale up in future years.

The Platform will provide end-to-end support ̶ consolidating global demand to shape the market; assisting countries with the selection of medicines; and contributing to the effective provision of services through the implementation of evidence-based standards of care.